Rani Therapeutics
RANI
RANI
34 hedge funds and large institutions have $10.9M invested in Rani Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $27K
Holders
34
Holding in Top 10
2
Calls
–
Puts
$27K
Top Buyers
| 1 | +$31.5K | |
| 2 | +$25.9K | |
| 3 | +$7.66K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$5.64K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$27 |
Top Sellers
| 1 | -$308K | |
| 2 | -$304K | |
| 3 | -$100K | |
| 4 |
ASGS
Alpha Square Group S
New York
|
-$93K |
| 5 |
Renaissance Technologies
New York
|
-$24.2K |